205 related articles for article (PubMed ID: 26425563)
21. Comparative clinical effectiveness of various 5-HT3 RA antiemetic regimens on chemotherapy-induced nausea and vomiting associated with hospital and emergency department visits in real world practice.
Hatoum HT; Lin SJ; Buchner D; Cox D
Support Care Cancer; 2012 May; 20(5):941-9. PubMed ID: 21533811
[TBL] [Abstract][Full Text] [Related]
22. Impact of 5-HT(3) RA selection within triple antiemetic regimens on uncontrolled highly emetogenic chemotherapy-induced nausea/vomiting.
Schwartzberg L; Jackson J; Jain G; Balu S; Buchner D
Expert Rev Pharmacoecon Outcomes Res; 2011 Aug; 11(4):481-8. PubMed ID: 21711119
[TBL] [Abstract][Full Text] [Related]
23. Addition of 3-day aprepitant to ondansetron and dexamethasone for prophylaxis of chemotherapy-induced nausea and vomiting among patients with diffuse large B cell lymphoma receiving 5-day cisplatin-based chemotherapy.
Abdel-Malek R; Abbas N; Shohdy KS; Ismail M; Fawzy R; Salem DS; Safwat E
J Egypt Natl Canc Inst; 2017 Sep; 29(3):155-158. PubMed ID: 28844591
[TBL] [Abstract][Full Text] [Related]
24. Palonosetron: an evidence-based choice in prevention of nausea and vomiting induced by moderately emetogenic chemotherapy.
Celio L; Agustoni F; Testa I; Dotti K; de Braud F
Tumori; 2012; 98(3):279-86. PubMed ID: 22825501
[TBL] [Abstract][Full Text] [Related]
25. New options and controversies in the management of chemotherapy-induced nausea and vomiting.
Koth SM; Kolesar J
Am J Health Syst Pharm; 2017 Jun; 74(11):812-819. PubMed ID: 28396308
[TBL] [Abstract][Full Text] [Related]
26. Olanzapine combined with 5-hydroxytryptamine type 3 receptor antagonist (5-HT3 RA) plus dexamethasone for prevention and treatment of chemotherapy-induced nausea and vomiting in high and moderate emetogenic chemotherapy: a systematic review and meta-analysis of randomised controlled trials.
Zhou JG; Huang L; Jin SH; Xu C; Frey B; Ma H; Gaipl US
ESMO Open; 2020 Feb; 5(1):. PubMed ID: 32079622
[TBL] [Abstract][Full Text] [Related]
27. Single-dose netupitant/palonosetron versus 3-day aprepitant for preventing chemotherapy-induced nausea and vomiting: a pooled analysis.
Navari RM; Binder G; Bonizzoni E; Clark-Snow R; Olivari S; Roeland EJ
Future Oncol; 2021 Aug; 17(23):3027-3035. PubMed ID: 33878896
[TBL] [Abstract][Full Text] [Related]
28. Prevention and management of chemotherapy-induced nausea and vomiting.
Moradian S; Howell D
Int J Palliat Nurs; 2015 May; 21(5):216, 218-24. PubMed ID: 26107543
[TBL] [Abstract][Full Text] [Related]
29. Meta-analysis of adjunctive non-NK1 receptor antagonist medications for the control of acute and delayed chemotherapy-induced nausea and vomiting.
Santana TA; Trufelli DC; Matos LL; Cruz FM; Del Giglio A
Support Care Cancer; 2015 Jan; 23(1):213-22. PubMed ID: 25145507
[TBL] [Abstract][Full Text] [Related]
30. The efficacy of triplet antiemetic therapy with 0.75 mg of palonosetron for chemotherapy-induced nausea and vomiting in lung cancer patients receiving highly emetogenic chemotherapy.
Miura S; Watanabe S; Sato K; Makino M; Kobayashi O; Miyao H; Iwashima A; Okajima M; Tanaka J; Tanaka H; Kagamu H; Yokoyama A; Narita I; Yoshizawa H
Support Care Cancer; 2013 Sep; 21(9):2575-81. PubMed ID: 23644992
[TBL] [Abstract][Full Text] [Related]
31. Results of a 7-day aprepitant schedule for the prevention of nausea and vomiting in 5-day cisplatin-based germ cell tumor chemotherapy.
Olver IN; Grimison P; Chatfield M; Stockler MR; Toner GC; Gebski V; Harrup R; Underhill C; Kichenadasse G; Singhal N; Davis ID; Boland A; McDonald A; Thomson D;
Support Care Cancer; 2013 Jun; 21(6):1561-8. PubMed ID: 23274926
[TBL] [Abstract][Full Text] [Related]
32. Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents.
Navari RM
J Support Oncol; 2003; 1(2):89-103. PubMed ID: 15352652
[TBL] [Abstract][Full Text] [Related]
33. Olanzapine with ondansetron and dexamethasone for the prevention of cisplatin-based chemotherapy-induced nausea and vomiting in lung cancer.
Wang W; Lou G; Zhang Y
Medicine (Baltimore); 2018 Sep; 97(37):e12331. PubMed ID: 30212982
[TBL] [Abstract][Full Text] [Related]
34. New and emerging therapeutic options for the management of chemotherapy-induced nausea and vomiting.
Schwartzberg LS; Rugo HS; Aapro MS
Clin Adv Hematol Oncol; 2015 Mar; 13(3 Suppl 3):3-13, 1; quiz 2 p following 14. PubMed ID: 25856052
[TBL] [Abstract][Full Text] [Related]
35. NEPA as antiemetic prophylaxis after failure of 5HT
Valerio MR; Gebbia V; Borsellino N; Vecchia M; Serretta V; Pardo S; Cipolla C; Galanti D
J Oncol Pharm Pract; 2021 Apr; 27(3):609-613. PubMed ID: 32507099
[TBL] [Abstract][Full Text] [Related]
36. Recent Advances in Antiemetics: New Formulations of 5-HT3 Receptor Antagonists in Adults.
Smith C; Smith M; Cunningham R; Davis S
Cancer Nurs; 2020; 43(4):E217-E228. PubMed ID: 30688665
[TBL] [Abstract][Full Text] [Related]
37. Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
Hamadani M; Chaudhary L; Awan FT; Khan JK; Kojouri K; Ozer H; Tfayli A
J Oncol Pharm Pract; 2007 Jun; 13(2):69-75. PubMed ID: 17873106
[TBL] [Abstract][Full Text] [Related]
38. Nausea and vomiting during post-transplantation cyclophosphamide administration.
Nakashima T; Inamoto Y; Ito A; Tanaka T; Kim SW; Fukuda T; Makino Y; Hashimoto H; Yamaguchi M
Int J Hematol; 2020 Oct; 112(4):577-583. PubMed ID: 32656635
[TBL] [Abstract][Full Text] [Related]
39. Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy.
Longo F; Mansueto G; Lapadula V; De Sanctis R; Quadrini S; Grande R; Gori B; Altavilla A; D'Antoni I; Del Signore E; Stumbo L; De Luca C; Cimadon B; Cortesi E; Gamucci T; Di Seri M
Support Care Cancer; 2011 Aug; 19(8):1159-64. PubMed ID: 20552375
[TBL] [Abstract][Full Text] [Related]
40. Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods.
Mahesh R; Perumal RV; Pandi PV
Pharmazie; 2005 Feb; 60(2):83-96. PubMed ID: 15739895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
